文献速递妇科

加速康复外科方案对阿片类药物使用及患者报告结局的影响

Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.
PubMed 文献 · Obstet Gynecol · 2018-01-01

该质量改进项目比较了实施加速康复外科(ERAS)方案前后接受开腹妇科手术的607例患者,其中293例使用MD安德森症状量表-卵巢癌模块评估患者报告结局。ERAS组中位住院时间缩短25%,中位阿片类药物消耗减少72%,16%的患者在术后第3天前未使用阿片类药物(P<.001),疼痛评分无差异(P=.80),疲劳和步行干扰等患者报告结局改善。

要点

  • ERAS方案使开腹妇科手术患者中位住院时间缩短25%(P<.001)。
  • ERAS组中位阿片类药物消耗减少72%,16%患者术后第3天前未用阿片类药物(P<.001)。
  • ERAS组疲劳和步行干扰等患者报告结局改善,疼痛评分无差异(P=.80)。

核心结论

  • 实施ERAS方案与开腹妇科手术后阿片类药物使用显著减少及功能恢复相关患者报告结局改善有关,且未影响疼痛评分。

研究设计与样本

  • 质量改进项目,比较实施ERAS方案前后接受开腹妇科手术的607例患者队列,其中293例使用MD安德森症状量表-卵巢癌模块评估患者报告结局。

主要发现

  • 中位年龄58岁(范围18-85岁)。
  • ERAS组中位住院时间缩短25%(P<.001)。
  • ERAS组中位阿片类药物消耗减少72%,16%的患者在术后第3天前未使用阿片类药物(P<.001)。
  • 疼痛评分无差异(P=.80)。
  • ERAS组住院期间疲劳(P=.01)、步行干扰(P=.003)和总干扰(P=.008)报告较少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effect of an enhanced recovery after surgery (ERAS) program on perioperative outcomes with an emphasis on opioid consumption and patient-reported outcomes in the immediate and extended postoperative periods. METHODS: We initiated our ERAS program as part of a quality improvement initiative in November 2014. We compared clinical outcomes among a cohort of 607 women undergoing open gynecologic surgery before or after implementation of ERAS. For 293 patients, patient-reported outcomes were compared using the MD Anderson Symptom Inventory-Ovarian Cancer. RESULTS: Median age was 58 years (range 18-85 years). Median length of stay decreased by 25% for patients in the ERAS pathway (P<.001). Overall, patients in the ERAS group had a 72% reduction in median opioid consumption and 16% were opioid-free during admission up to postoperative day 3 (P<.001). There was no difference in pain scores (P=.80). Patients on ERAS reported less fatigue (P=.01), interference with walking (P=.003), and total interference (composite score of physical and affective measures) during hospitalization (P=.008). After discharge, those on the ERAS pathway demonstrated a significantly shorter median time to return to no or mild fatigue (10 vs 30 days, P=.03), mild or no interference with walking (5 vs 13 days, P=.003), and mild to no total interference (3 vs 13 days, P=.02). There were no significant differences in complications, rates of readmission, or reoperation between the pre- and post-ERAS groups. CONCLUSION: Implementation of an ERAS program was associated with significantly decreased opioid use after surgery and improvement in key patient-reported outcomes associated with functional recovery after surgery without compromising pain scores.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Meyer LA, Lasala J, Iniesta MD, et al. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol. 2018. PMID: 29995737. doi:10.1097/AOG.0000000000002735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。